AAPL 168.85 -0.1006% MSFT 392.79 -3.9774% GOOG 156.37 -2.9361% GOOGL 154.51 -2.9033% AMZN 170.725 -3.3213% NVDA 815.097 2.3002% META 431.97 -12.4681% TSLA 165.815 2.2729% TSM 133.785 0.6129% LLY 719.89 -1.6812% V 270.7 -1.5708% AVGO 1290.37 2.6694% JPM 193.02 -0.0311% UNH 494.02 1.379% NVO 124.29 -1.4822% WMT 60.13 0.4343% LVMUY 166.98 -2.7036% XOM 120.27 -0.6444% LVMHF 859.75 -0.3073% MA 457.42 -1.0984%
Last update at 2024-04-25T14:58:00Z
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Income before tax | -2.45300M | 66.01M | 29.35M | 73.93M | 35.62M |
| Minority interest | - | - | - | - | - |
| Net income | 5.65M | 77.85M | 32.19M | 61.34M | 37.73M |
| Selling general administrative | 486.34M | 389.43M | 307.61M | 289.92M | 263.10M |
| Selling and marketing expenses | - | - | - | - | - |
| Gross profit | 588.99M | 554.65M | 413.29M | 436.91M | 372.33M |
| Reconciled depreciation | 99.17M | 84.93M | 71.59M | 64.12M | 51.35M |
| Ebit | -2.32300M | 89.51M | 35.53M | 78.35M | 44.39M |
| Ebitda | 96.85M | 174.44M | 107.12M | 142.47M | 95.74M |
| Depreciation and amortization | 99.17M | 84.93M | 71.59M | 64.12M | 51.35M |
| Non operating income net other | -0.13000M | -23.50000M | -6.17700M | -4.41900M | -8.77600M |
| Operating income | -2.32300M | 89.51M | 35.53M | 78.35M | 44.39M |
| Other operating expenses | 1298.27M | 1042.51M | 856.68M | 818.67M | 742.92M |
| Interest expense | 0.13M | -23.50000M | -6.17700M | -4.41900M | 8.78M |
| Tax provision | -8.10100M | -11.84200M | -2.84500M | 12.60M | -2.11300M |
| Interest income | - | - | - | 4.42M | 8.78M |
| Net interest income | -0.13000M | -23.50000M | -6.17700M | -4.41900M | -8.77600M |
| Extraordinary items | - | - | - | - | - |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | -8.10100M | -11.84200M | -2.84500M | 12.60M | -2.11300M |
| Total revenue | 1295.95M | 1132.02M | 892.21M | 897.03M | 787.31M |
| Total operating expenses | 591.31M | 465.15M | 377.77M | 358.56M | 327.94M |
| Cost of revenue | 706.96M | 577.37M | 478.92M | 460.12M | 414.98M |
| Total other income expense net | -0.13000M | -23.50000M | -6.17700M | -4.41900M | -8.77600M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | 5.65M | 77.85M | 32.19M | 61.34M | 37.73M |
| Net income applicable to common shares | 5.65M | 77.85M | 32.19M | 61.34M | 37.73M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Total assets | 2210.76M | 2142.50M | 1824.50M | 1240.81M | 1081.24M |
| Intangible assets | 242.91M | 277.62M | 168.21M | 124.87M | 143.69M |
| Earning assets | - | - | - | - | - |
| Other current assets | 77.36M | 48.33M | 41.04M | 15.18M | 12.14M |
| Total liab | 1080.62M | 995.81M | 857.00M | 395.56M | 401.62M |
| Total stockholder equity | 1130.14M | 1146.69M | 967.50M | 845.25M | 679.62M |
| Deferred long term liab | 2.10M | 51.70M | 4.25M | 39.09M | 41.48M |
| Other current liab | 235.35M | 204.30M | 123.86M | 89.66M | 75.71M |
| Common stock | 0.06M | 0.05M | 0.05M | 0.05M | 0.05M |
| Capital stock | 0.06M | 0.05M | 0.05M | 0.05M | 0.05M |
| Retained earnings | 390.73M | 368.57M | 290.72M | 258.79M | 197.45M |
| Other liab | 46.20M | 79.74M | 64.48M | 57.89M | 61.63M |
| Good will | 734.27M | 738.90M | 499.31M | 336.54M | 335.89M |
| Other assets | 138.99M | 225.59M | 268.50M | 100.72M | 96.22M |
| Cash | 330.36M | 349.05M | 485.93M | 127.21M | 67.19M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 428.45M | 876.16M | 276.42M | 237.00M | 204.58M |
| Current deferred revenue | 118.95M | 112.20M | 100.05M | 90.89M | 81.83M |
| Net debt | 286.38M | 179.01M | 30.17M | -26.54100M | 68.22M |
| Short term debt | 10.76M | 488.15M | 12.20M | 10.06M | 8.99M |
| Short long term debt | - | 488.15M | - | - | - |
| Short long term debt total | 616.74M | 528.06M | 516.10M | 100.67M | 135.42M |
| Other stockholder equity | 756.44M | 786.47M | 682.25M | 595.86M | 492.97M |
| Property plant equipment | 93.96M | 119.69M | 59.07M | 54.25M | 51.50M |
| Total current assets | 881.81M | 780.70M | 829.41M | 483.24M | 397.13M |
| Long term investments | 32.92M | 18.39M | 22.16M | 19.75M | 17.08M |
| Net tangible assets | 152.96M | 130.17M | 967.50M | 845.25M | 200.04M |
| Short term investments | 11.49M | 10.66M | 10.25M | - | - |
| Net receivables | 299.47M | 240.89M | 190.12M | 218.36M | 196.24M |
| Long term debt | 566.57M | - | 467.20M | 50.00M | 135.42M |
| Inventory | 147.55M | 119.92M | 96.30M | 108.01M | 100.87M |
| Accounts payable | 63.39M | 71.51M | 40.31M | 46.38M | 38.04M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | -17.08700M | -8.40700M | -5.52200M | -9.44600M | -10.85400M |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | 0.06M | 0.05M | 0.05M | 0.05M | 0.05M |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | 390.73M | 368.57M | 290.72M | 258.79M | 197.45M |
| Treasury stock | -290.31900M | -238.10900M | -238.10900M | -185.07400M | -185.07400M |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 164.50M | 191.31M | 176.21M | 151.90M | 120.76M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 1328.95M | 1361.79M | 995.09M | 757.57M | 684.11M |
| Capital lease obligations | 50.17M | 39.91M | 48.90M | 60.73M | - |
| Long term debt total | 566.57M | - | 467.20M | 50.00M | 135.42M |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Investments | -58.66900M | -412.49800M | -279.86600M | -61.66400M | -54.37400M |
| Change to liabilities | 10.64M | 53.26M | 17.12M | 19.44M | 11.82M |
| Total cashflows from investing activities | -58.66900M | -412.49800M | -279.86600M | -61.66400M | -54.37400M |
| Net borrowings | - | - | 408.49M | -92.32100M | -77.00000M |
| Total cash from financing activities | -20.95300M | 47.36M | 456.27M | -23.47900M | -13.59700M |
| Change to operating activities | 0.29M | 10.06M | -13.22100M | 0.52M | 8.37M |
| Net income | 5.65M | 77.85M | 32.19M | 61.34M | 37.73M |
| Change in cash | -2.78500M | -134.30000M | 362.71M | 60.02M | 34.77M |
| Begin period cash flow | 355.62M | 489.92M | 127.21M | 67.19M | 32.42M |
| End period cash flow | 352.83M | 355.62M | 489.92M | 127.21M | 67.19M |
| Total cash from operating activities | 77.78M | 231.81M | 185.87M | 145.01M | 103.97M |
| Issuance of capital stock | - | 0.00000M | 0.00000M | 37.81M | 39.57M |
| Depreciation | 99.17M | 84.93M | 71.59M | 64.12M | 51.35M |
| Other cashflows from investing activities | -11.13300M | -383.53100M | -257.02400M | -45.77000M | -30.67700M |
| Dividends paid | - | - | - | - | - |
| Change to inventory | -30.11500M | -25.69500M | 12.36M | -8.12300M | -6.76300M |
| Change to account receivables | -60.35700M | -43.22000M | 12.03M | -23.52000M | -6.19200M |
| Sale purchase of stock | -52.21000M | 67.35M | -53.03500M | 78.51M | 70.18M |
| Other cashflows from financing activities | 31.26M | 47.36M | 709.30M | 28.71M | 23.84M |
| Change to netincome | 31.61M | 50.32M | 38.42M | 33.16M | 23.31M |
| Capital expenditures | 60.74M | 58.34M | 54.87M | 61.66M | 54.37M |
| Change receivables | -75.71100M | -37.62700M | 33.96M | -25.23900M | -7.87200M |
| Cash flows other operating | 44.61M | 10.61M | -15.61600M | 8.68M | -7.90600M |
| Exchange rate changes | - | -0.97400M | 0.44M | 0.15M | -1.22700M |
| Cash and cash equivalents changes | -1.84100M | -134.30000M | 362.71M | 60.02M | 34.77M |
| Change in working capital | -73.46600M | -3.34000M | 37.30M | -15.81000M | -10.71800M |
| Stock based compensation | 68.25M | 53.16M | 44.70M | 34.05M | 28.89M |
| Other non cash items | 15.50M | 22.48M | 6.63M | 2.65M | 2.42M |
| Free cash flow | 17.04M | 173.47M | 131.00M | 83.34M | 49.59M |
Sector: Healthcare Industry: Health Information Services
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| OMCL Omnicell Inc |
-0.44 1.60% | 26.99 | - | 29.50 | 1.50 | 1.45 | 1.58 | 40.32 |
| GEHC GE HealthCare Technologies Inc. |
-1.89 2.18% | 84.83 | 22.39 | 17.33 | 1.78 | 4.79 | 2.18 | 11.79 |
| VEEV Veeva Systems Inc Class A |
-3.34 1.67% | 197.18 | 54.61 | 33.22 | 12.83 | 6.73 | 11.14 | 58.84 |
| MTHRF M3 Inc |
- -% | 14.60 | 29.72 | 25.00 | 0.05 | 4.38 | 0.04 | 0.12 |
| MTHRY M3 Inc |
-0.0899 1.48% | 5.98 | 31.84 | 26.25 | 0.05 | 4.60 | 0.04 | 0.12 |
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Santa Clara, California.
590 East Middlefield Road, Mountain View, CA, United States, 94043
| Name | Title | Year Born |
|---|---|---|
| Mr. Randall A. Lipps | Founder, Exec. Chairman, Pres & CEO | 1957 |
| Mr. Peter J. Kuipers | Exec. VP & CFO | 1972 |
| Ms. Christine Mellon | Exec. VP, Chief Admin. & People Officer | 1963 |
| Mr. Scott Peter Seidelmann | Exec. VP & Chief Commercial Officer | 1976 |
| Mr. Joseph Brian Spears | Sr. VP, Chief Accounting Officer & Corp. Controller | 1960 |
| Mr. Giri Chodavarapu | Sr. VP & Chief Information Officer | NA |
| Ms. Kathleen Nemeth | Sr. VP of Investor Relations | NA |
| Mr. Corey J. Manley | Sr. VP & Chief Legal Officer | NA |
| Ms. Roxanne Turner | Sr. VP of Corp. Responsibility and Chief Compliance & Privacy Officer | NA |
| Mr. Jorge R. Taborga | Exec. VP of Engineering & Integration Management Officer | 1959 |
Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).
US 
AU
UK
CA
NZ
Please wait processing your request...